This inventor holds 2 USPTO granted patents and 5 published patent applications and 1 EPO patent. Top assignee: Novozymes A/s. Active years: 2012-2013.
Company Filing History:
Years Active: 2012-2013
Title: Jon Martin Persson: Innovator in Recombinant Nuclease Technology
Introduction
Jon Martin Persson is a notable inventor based in Bjärred, Sweden. He has made significant contributions to the field of biotechnology, particularly in the area of recombinant nuclease technology. With a total of 2 patents to his name, Persson's work has the potential to impact various applications in the life sciences.
Latest Patents
One of Jon Martin Persson's latest patents focuses on "DNase expression in recombinant host cells." This invention relates to cells that produce at least one polypeptide of interest while expressing one or more recombinant nuclease encoding genes. The method outlined in the patent involves cultivating a cell that produces the desired polypeptide and isolating it essentially free from contaminating DNA. This innovative approach enhances the efficiency of producing valuable proteins in a controlled environment.
Career Highlights
Jon Martin Persson is currently employed at Novozymes A/S, a leading company in the field of biotechnology. His work at Novozymes allows him to apply his expertise in recombinant technology to develop solutions that address various challenges in the industry. His contributions have been instrumental in advancing the company's research and development efforts.
Collaborations
Jon Martin Persson collaborates with Michael Dolberg Rasmussen, working together to push the boundaries of innovation in their field. Their partnership exemplifies the importance of teamwork in driving scientific advancements.
Conclusion
Jon Martin Persson is a distinguished inventor whose work in recombinant nuclease technology is paving the way for new advancements in biotechnology. His patents and contributions at Novozymes A/S highlight his commitment to innovation and excellence in the field.